Stocks
Teva Pharmaceutical Industries (TEVA) Debt/EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| Debt/EBITDA | 4.83 | -20.3 | 10.9 | 3.34 | 4.40 | 4.03 | ||
| Changes by years, y/y, % | -142% | -520% | -154% | -69% | +32% | |||
Teva Pharmaceutical Industries. Debt/EBITDA
Teva Pharmaceutical Industries. Debt/EBITDA, changes, %
Teva Pharmaceutical Industries (TEVA) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Debt/EBITDA | 6.41 | 5.51 | 4.04 | 4.38 | 4.03 | 4.03 | ||
| Changes by years, y/y, % | +20% | -19% | -49% | -50% | -37% | |||
| Changes by quarters, q/q, % | -28% | -14% | -27% | +8% | -8% | |||
